What is the latest John Hopkins research on magic mushrooms
Johns Hopkins University has been at the forefront of psychedelic research, including studies on magic mushrooms (psilocybin). Some of the notable research conducted by Johns Hopkins in this field includes:
Johns Hopkins researchers conducted a study exploring the potential of psilocybin-assisted therapy for smoking cessation. The study found that psilocybin sessions, combined with cognitive-behavioral therapy, resulted in higher rates of smoking abstinence compared to standard cognitive-behavioral therapy alone.
Johns Hopkins researchers have conducted several studies investigating the effects of psilocybin on depression and anxiety, particularly in individuals with terminal illnesses. These studies have shown that a single dose of psilocybin can lead to significant reductions in depression and anxiety, as well as improvements in mood, quality of life, and existential distress.
Johns Hopkins researchers have explored the relationship between mystical experiences induced by psilocybin and subsequent improvements in psychological well-being and life satisfaction. Studies have found that individuals who report having profound mystical experiences during psilocybin sessions tend to have better outcomes in terms of psychological well-being and positive behavior change.
Johns Hopkins researchers have used neuroimaging techniques such as functional magnetic resonance imaging (fMRI) and magnetoencephalography (MEG) to investigate the neural correlates of psilocybin-induced altered states of consciousness. These studies have provided insights into the changes in brain connectivity and activity patterns associated with the acute effects of psilocybin.